Deborah Kuban

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi High-dose intensity modulated radiation therapy for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology, M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77007, USA
    Curr Urol Rep 5:197-202. 2004
  2. ncbi Comparison of biochemical failure definitions for permanent prostate brachytherapy
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 65:1487-93. 2006
  3. ncbi Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 70:67-74. 2008
  4. ncbi Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:915-28. 2003
  5. ncbi Hazards of dose escalation in prostate cancer radiotherapy
    Deborah Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 57:1260-8. 2003
  6. ncbi Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy
    Deborah A Kuban
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, TX 77030, Houston, USA
    World J Urol 21:253-64. 2003
  7. ncbi Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 79:1310-7. 2011
  8. ncbi PSA after radiation for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77007, USA
    Oncology (Williston Park) 18:595-604; discussion 605, 609. 2004
  9. ncbi Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
    Deborah Kuban
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 61:409-14. 2005
  10. ncbi Ultrasound-based localization
    Deborah A Kuban
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Semin Radiat Oncol 15:180-91. 2005

Detail Information

Publications90

  1. ncbi High-dose intensity modulated radiation therapy for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology, M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77007, USA
    Curr Urol Rep 5:197-202. 2004
    ..This technique continues to evolve, working toward image-guided radiation therapy, which is adjusted daily for positional and architectural changes of the gland...
  2. ncbi Comparison of biochemical failure definitions for permanent prostate brachytherapy
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 65:1487-93. 2006
    ..To assess prostate-specific antigen (PSA) failure definitions for patients with Stage T1-T2 prostate cancer treated by permanent prostate brachytherapy...
  3. ncbi Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 70:67-74. 2008
    ..To report the long-term results of a randomized radiotherapy dose escalation trial for prostate cancer...
  4. ncbi Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:915-28. 2003
    ..To report the long-term outcome for patients with Stage T1-T2 adenocarcinoma of the prostate definitively irradiated in the prostate-specific antigen (PSA) era...
  5. ncbi Hazards of dose escalation in prostate cancer radiotherapy
    Deborah Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 57:1260-8. 2003
    ..To assess the benefit of escalating the dose in definitive prostate cancer radiotherapy vs. the associated risk of complications...
  6. ncbi Radiation for prostate cancer: use of biochemical failure as an endpoint following radiotherapy
    Deborah A Kuban
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, TX 77030, Houston, USA
    World J Urol 21:253-64. 2003
    ..A summary of these results and the associated issues are presented here...
  7. ncbi Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 79:1310-7. 2011
    ..To report long-term failure patterns and survival in a randomized radiotherapy dose escalation trial for prostate cancer...
  8. ncbi PSA after radiation for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77007, USA
    Oncology (Williston Park) 18:595-604; discussion 605, 609. 2004
    ..The concept of a universal definition of failure that might be applied to multiple modalities, including surgery, should also be investigated, at least for comparative study and research purposes...
  9. ncbi Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?
    Deborah Kuban
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 61:409-14. 2005
    ..To compare long-term outcome using alternative failure definitions after external beam radiation for localized prostate cancer...
  10. ncbi Ultrasound-based localization
    Deborah A Kuban
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Semin Radiat Oncol 15:180-91. 2005
    ..For breast cancer radiotherapy, ultrasound serves to define involved primary and nodal sites, especially in patients in whom surgical evaluation will not be the first therapeutic step...
  11. ncbi Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995
    Patrick Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 61:415-9. 2005
    ..To study the radiation dose-response as determined by Kaplan-Meier prostate-specific antigen (PSA) disease-free survival (PSA-DFS) estimates in patients with stage T1-T2 prostate cancer treated within a 2-year period (1994-1995)...
  12. ncbi The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995
    Howard D Thames
    Division of Quantitative Sciences, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Radiother Oncol 96:6-12. 2010
    ..Assess the importance of overall time (OT) and dose for biochemical failure (BF) after external-beam radiotherapy of prostate cancer in a retrospective analysis of a nine-institution database with 4839 patients...
  13. ncbi Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995
    Howard Thames
    Department of Biomathematics, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:929-43. 2003
    ....
  14. ncbi Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy
    Susan L Tucker
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 60:1589-601. 2004
    ..To compare the fits of normal-tissue complication probability (NTCP) models based on rectal dose-wall histograms (DWHs) vs. dose-volume histograms (DVHs) when the two are used to analyze a common set of late rectal toxicity data...
  15. ncbi Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer
    M Rex Cheung
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 67:1059-65. 2007
    ..We sought to identify the bladder dose-volume factors associated with an increased risk of late urinary toxicity among prostate cancer patients treated with radiotherapy...
  16. ncbi Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer
    Susan L Tucker
    Department of Biostatistics and Applied Mathematics, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 59:353-65. 2004
    ..To compare the fits of various normal tissue complication probability (NTCP) models to a common set of late rectal toxicity data, with the aim of identifying the best model for predicting late rectal injury after irradiation...
  17. ncbi An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer
    Laurence E Court
    Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:154-63. 2005
    ....
  18. ncbi Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era
    Patrick Kupelian
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    Int J Radiat Oncol Biol Phys 63:795-9. 2005
    ..Accounting for these changes would facilitate the retrospective comparison of outcomes for patients treated in different periods...
  19. ncbi Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy
    Rex Cheung
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:134-40. 2005
    ..By comparing the outcomes for patients who received RT alone and for those who received combined RT and hormonal therapy, we assessed the potential benefits of hormonal therapy...
  20. ncbi Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
    Mary Feng
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 68:1417-23. 2007
    ..To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities...
  21. ncbi Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model
    Susan L Tucker
    Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
    Int J Radiat Oncol Biol Phys 78:1253-60. 2010
    ....
  22. ncbi Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study
    Susan L Tucker
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 64:1255-64. 2006
    ..The purpose of this study was to test the validity of a two-dimensional cluster model of late rectal toxicity based on maximum cluster size of damage to rectal surface...
  23. ncbi Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy
    Rex Cheung
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 61:993-1002. 2005
    ..We also investigated the differences in the dose-response characteristics using the American Society for Therapeutic Radiology and Oncology (ASTRO) definition vs. an alternative biochemical failure definition...
  24. ncbi Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes
    Radhe Mohan
    Department of Radiation Physics, Unit 94, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 61:1258-66. 2005
    ..In this paper, we report the development of one such intermediate method that takes into account anatomic changes by deforming the intensity distributions of each beam based on deformations of anatomy as seen in the beam's-eye-view...
  25. ncbi Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy
    Andrew K Lee
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 63:456-62. 2005
    ..To determine whether prostate-specific antigen (PSA) doubling time predicts clinical outcomes in patients with prostate cancer that has been treated with combined radiation and hormone therapy...
  26. ncbi Comparison of treatment volumes and techniques in prostate cancer radiation therapy
    Catherine T Lee
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Am J Clin Oncol 28:618-25. 2005
    ..Because dose-volume parameters have been shown to relate to toxicity, IMRT would appear to be the favored technique for prostate cancer radiation, particularly with regard to nodal treatment...
  27. ncbi Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy
    Lei Dong
    Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 66:883-91. 2006
    ..CT-guided alignment provided the best and most consistent dosimetric coverage. A larger planning target volume margin is needed for SV coverage when the alignment target is the prostate...
  28. ncbi Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer
    Rex Cheung
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 58:1513-9. 2004
    ..This study analyzed the utility and limitations of the widely used Lyman-Kutcher- Burman (LKB) normal tissue complication probability model in projecting the hazards of rectal complication with high-dose RT...
  29. ncbi Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation
    Charles J Rosser
    Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 168:536-41. 2002
    ..CONCLUSIONS: Men with prostate cancer who are 60 years or younger and treated with radiotherapy may be at significant risk for long-term biochemical failure...
  30. ncbi Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy
    Renaud de Crevoisier
    Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:965-73. 2005
    ..Therefore, an empty rectum is warranted at the time of simulation. These results also emphasize the need for image-guided radiotherapy to improve local control in irradiating prostate cancer...
  31. ncbi PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
    Michael E Ray
    Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
    Int J Radiat Oncol Biol Phys 64:1140-50. 2006
    ....
  32. ncbi Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate
    Charles J Rosser
    Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 169:2160-5. 2003
    ..Patients are at slight but persistent risk for biochemical failure more than 5 years after treatment. Hazard rate calculations beyond the median followup of 4 years can underestimate the true hazard...
  33. ncbi Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial
    Alan Pollack
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 54:677-85. 2002
    ..These issues were investigated in a cohort of men with Stage T1-T3 prostate cancer who were randomized to receive between 70 Gy and 78 Gy and were prospectively biopsied at about 2 years after the completion of radiotherapy (RT)...
  34. ncbi Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy
    Rex Cheung
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Boulevard, Box 97, Houston, TX 77030-4009, USA
    Int J Radiat Oncol Biol Phys 56:1234-40. 2003
    ..There is a steep dose response in PSA control probability around a modern dose of 78 Gy. A 5-Gy dose increase beyond 78 Gy may improve PSA control by about 10%...
  35. ncbi Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study
    Laurence E Court
    Department of Radiation Physics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA
    Int J Radiat Oncol Biol Phys 59:412-8. 2004
    ..The use of a reference image is important to improve the consistency among different users in this technique...
  36. ncbi Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins
    Darren J Little
    Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1218-24. 2003
    ..Relatively large planning target volume margins in the AP and SI dimensions may be necessary to overcome this...
  37. ncbi Experience of ultrasound-based daily prostate localization
    Anurag Chandra
    Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:436-47. 2003
    ..Although the accuracy of the BAT was not addressed in this investigation, we found a significant percentage of large shifts being made from the initial alignment position...
  38. ncbi Defining recurrence after radiation for prostate cancer
    Deborah A Kuban
    Department of Radiation Oncology and Biostatistics, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    J Urol 173:1871-8. 2005
    ..The application of a universal PSA definition of tumor recurrence across multiple treatment modalities should also be explored...
  39. ncbi Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer
    Ugur Selek
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:963-7. 2003
    ..CONCLUSION: PPPB was a predictor of post-external beam radiotherapy PSA outcome in clinically localized prostate cancer; but in this cohort it did not provide additional information beyond the traditional risk stratification schema...
  40. ncbi Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer
    Renaud de Crevoisier
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1529-36. 2007
    ..To quantify the three-dimensional variations of pelvic anatomy after a single treatment fraction...
  41. ncbi Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy
    Jennifer C O'Daniel
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:274-80. 2008
    ....
  42. ncbi Stage T1c prostate cancer: a heterogeneous category with widely varying prognosis
    Arthur Y Hung
    Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer J 8:440-4. 2002
    ..Improvement in prostate imaging and multiple core biopsies may be helpful in better defining the extent of disease in the individual patient...
  43. ncbi Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer
    Eugene H Huang
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Radiat Oncol Biol Phys 54:1314-21. 2002
    ..Therefore, dose escalation may be safely achieved by adherence to dose-volume histogram constraints during treatment planning and organ localization at the time of treatment to ensure consistent patient setup...
  44. ncbi Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy
    Stephen F Kry
    Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:1204-16. 2005
    ..This information is useful in determining the dose to critical structures and in evaluating the risk of associated carcinogenesis...
  45. ncbi Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
    Michael J Zelefsky
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 67:327-33. 2007
    ..To assess long-term prostate-specific antigen (PSA) outcome after permanent prostate brachytherapy (BT) and identify predictors of improved disease-free survival...
  46. ncbi Erectile dysfunction and radiation dose to penile base structures: a lack of correlation
    Ugur Selek
    Department of Radiation Oncology, Unit 97, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 59:1039-46. 2004
    ..The entire etiology of radiation- induced erectile dysfunction remains unclear and further research is needed...
  47. ncbi Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy
    Ashish M Kamat
    Department of Urology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 170:1860-3. 2003
    ..9 ng/ml at presentation are at increased risk for recurrence after adjuvant RT...
  48. ncbi Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
    Eric M Horwitz
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
    Cancer 107:1496-502. 2006
    ....
  49. ncbi Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer
    Sara S Strom
    Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:631-9. 2006
    ..The current study sought to determine whether obesity was an independent predictor of biochemical failure (BF) and clinical recurrence (CF) among patients treated with external-beam radiotherapy (EBRT)...
  50. ncbi The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome
    Waseet Vance
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 67:828-33. 2007
    ..To determine the value of a 2-year post-radiotherapy (RT) prostate biopsy for predicting eventual biochemical failure in patients who were treated for localized prostate cancer...
  51. ncbi Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer
    Charles J Rosser
    Department of Urology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA
    J Urol 168:2001-5. 2002
    ..The PSA bounce phenomenon was not predictive of time to biochemical recurrence...
  52. ncbi Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure
    Michael E Ray
    Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
    Urology 68:1257-62. 2006
    ..To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk...
  53. ncbi Quality-of-life questionnaire results 2 and 3 years after radiotherapy for prostate cancer in a randomized dose-escalation study
    Darren J Little
    Department of Radiation Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    Urology 62:707-13. 2003
    ..Comparing the results 2 and 3 years after radiotherapy, the symptoms of rectal bleeding had improved, erectile function had decreased, and urinary urge incontinence had increased...
  54. ncbi Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States
    Steven J Frank
    Department of Radiation Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Brachytherapy 6:2-8. 2007
    ..This study is aimed at understanding and defining the current patterns of care with respect to prostate brachytherapy for patients with intermediate-risk localized disease in the combined academic and community setting...
  55. ncbi Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
    Rajat J Kudchadker
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 72:623-7. 2008
    ..To characterize the amount of activity required to treat the prostate with stranded (125)I radioactive seeds and compare our stranded data with the amount of activity recommended when individual seeds are implanted using a Mick applicator...
  56. ncbi Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy
    Steven J Frank
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    J Urol 181:1658-63; discussion 1663-4. 2009
    ..We examined whether the Prostogram accurately predicted recurrence at 5 years in patients treated with (125)I brachytherapy at 1 tertiary cancer center...
  57. ncbi Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy
    Stephen F Kry
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 68:1265-71. 2007
    ..This work examines the uncertainty in absolute risk estimates and in the ratio of risk estimates between different treatment modalities...
  58. ncbi Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter
    Oleg N Vassiliev
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 68:1567-71. 2007
    ....
  59. ncbi Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment
    Xiaodong Zhang
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 67:620-9. 2007
    ..To determine the dosimetric impact of interfraction anatomic movements in prostate cancer patients receiving proton therapy...
  60. ncbi Quantification of prostate and seminal vesicle interfraction variation during IMRT
    Steven J Frank
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:813-20. 2008
    ....
  61. ncbi Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy
    Shi Ming Tu
    Department of Genitourinary Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 115:2872-80. 2009
    ..The authors of this report investigated the clinical outcome of patients who had prostate ductal adenocarcinoma after primary radical prostatectomy or radiotherapy...
  62. ncbi A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy
    Steven J Frank
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Clin Oncol 33:173-5. 2010
    ....
  63. ncbi An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer
    Steven J Frank
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 177:2151-6; discussion 2156. 2007
    ..Monotherapy with radical prostatectomy, high dose external beam radiotherapy or a (125)I implant is reported to produce equivalent outcomes. We assessed the health related quality of life associated with these 3 treatment approaches...
  64. ncbi First-year PSA kinetics and minima after prostate cancer radiotherapy are predictive of overall survival
    Rex Cheung
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 66:20-4. 2006
    ..We analyzed whether first-year prostate-specific antigen (PSA) kinetics and minima are predictive of overall survival (OS)...
  65. ncbi Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy
    Rex Cheung
    Departments of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 61:14-9. 2005
    ..We assessed the effect of using an alternative failure definition on the dose-response characteristics of high-risk prostate cancer treated with radiotherapy alone...
  66. ncbi Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer
    Hoon K Lee
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:355-61. 2003
    ..An alternative position for a surrogate urethra accounting for the difference in the location of the Foley catheter near the base of the prostate at Day 0 and 1 month could be considered in future studies...
  67. ncbi Symptomatic local recurrence of prostate carcinoma after radiation therapy
    Dan Leibovici
    Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:2060-6. 2005
    ..Aggressive histologic subtypes were predictive of this endpoint. Clinical T classification, Gleason score, and initial prostate-specific antigen levels also may have predictive value...
  68. ncbi Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma
    Charles J Rosser
    Department of Urology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1-6. 2003
    ....
  69. ncbi Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 185:116-20. 2011
    ....
  70. ncbi The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy
    Stephen F Kry
    Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:1195-203. 2005
    ..Perhaps this risk should be considered when choosing the optimal treatment technique and delivery system for patients who will undergo prostate radiation...
  71. ncbi Increasing external beam dose for T1-T2 prostate cancer: effect on risk groups
    Howard D Thames
    Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, and Department of Radiation Oncology, William Beaumont Hospital, Deroit, MI, USA
    Int J Radiat Oncol Biol Phys 65:975-81. 2006
    ....
  72. ncbi Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
    Alan Pollack
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 53:1097-105. 2002
    ..A randomized radiotherapy dose escalation trial was undertaken between 1993 and 1998 to compare the efficacy of 70 vs. 78 Gy in controlling prostate cancer...
  73. ncbi Impact of androgen deprivation therapy on survival in men treated with radiation for prostate cancer
    Alan Pollack
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA
    Urology 60:22-30; discussion 30-1. 2002
    ..The results with long-term ADT are much more convincing than short-term ADT, and, as a consequence, 2 to 3 years are recommended...
  74. ncbi Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy
    Charles J Rosser
    Department of Urology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Urol 170:1856-9. 2003
    ..Improved screening and early detection may improve disease-free survival in Hispanic men with localized prostate cancer...
  75. ncbi Intrafraction prostate motion during IMRT for prostate cancer
    Eugene Huang
    Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 53:261-8. 2002
    ..Intrafraction motion was much smaller than interfraction motion, and the two types of movement did not correlate...
  76. ncbi The delivery of IMRT with a single physical modulator for multiple fields: a feasibility study for paranasal sinus cancer
    Lei Dong
    Department of Radiation Physics, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 58:876-87. 2004
    ..Clinics may find it worthwhile to commit the minimal extra time for quality assurance and treatment to benefit from the improved dose distribution and lack of interplay between MLC leaf motion and internal target motion...
  77. ncbi Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability
    WARREN D D'SOUZA
    Department of Radiation Physics, University of Texas M D Anderson Cancer Center, Houston, TX, USA
    Int J Radiat Oncol Biol Phys 58:1540-8. 2004
    ..g., moderate underdosing of large volumes vs. extreme underdosing of small volumes)...
  78. ncbi Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method
    He Wang
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Int J Radiat Oncol Biol Phys 72:210-9. 2008
    ..The goal of this study was to quantitatively evaluate the performance of the algorithm in typical clinical applications...
  79. ncbi Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
    Adam D Melancon
    Department of Radiation Physics, The University of Texas M D Anderson Cancer Center, USA
    Radiother Oncol 85:251-9. 2007
    ....
  80. ncbi Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy
    He Wang
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Phys Med Biol 50:2887-905. 2005
    ..Together, these results suggest that the accelerated demons algorithm has significant potential for delineating and tracking doses in targets and critical structures during CT-guided radiotherapy...
  81. ncbi Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy
    He Wang
    Department of Radiation Physics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 61:725-35. 2005
    ..610 to 0.944 after registration of the two patient CT sets. CONCLUSION: The algorithm had an accuracy of about 1 mm. It could be used for optimizing dose calculation and delivery for prostate radiotherapy...
  82. ncbi Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis
    Eric M Horwitz
    Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 2497, USA
    J Urol 173:797-802. 2005
    ..In this report we determined the sensitivity and specificity of several BF definitions using distant failure (DF) alone or clinical failure (CF), defined as local failure (LF) and/or DF...
  83. ncbi Toward a real-time in vivo dosimetry system using plastic scintillation detectors
    Louis Archambault
    Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 78:280-7. 2010
    ..In the present study, we have presented and validated a plastic scintillation detector (PSD) system designed for real-time multiprobe in vivo measurements...
  84. ncbi Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer
    Charles J Rosser
    Department of Urology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Natl Med Assoc 96:939-44. 2004
    ..Continued diligence in screening and early detection may improve prostate cancer outcome for other minority populations...
  85. ncbi A multidisciplinary prostate cancer clinic for newly diagnosed patients: developing the role of the advanced practice nurse
    Lydia T Madsen
    Department of Genitourinary Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX, USA
    Clin J Oncol Nurs 13:305-9. 2009
    ..Formal evaluation of the MPCC showed that patients were satisfied with this approach to the complex decision-making process in prostate cancer...
  86. ncbi Surgical management of prostate cancer metastatic to the spine
    Brian J Williams
    Department of Neurosurgery, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Neurosurg Spine 10:414-22. 2009
    ..In this study, a series of patients undergoing spinal surgery for metastatic prostate cancer were reviewed to identify predictors of survival and functional outcome...
  87. ncbi Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience
    John F Anderson
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 74:601-5. 2009
    ..To minimize the risk of long-term urinary morbidity, it is important for clinicians to be able to distinguish acute urinary side effects after prostate brachytherapy from longer-term treatment-related urinary complications...
  88. ncbi Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?
    Charles J Rosser
    Department of Urology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Urology 66:327-31. 2005
    ..To evaluate the effect of patient age on the occurrence of prostate-specific antigen (PSA) "bounce" after external beam radiotherapy (EBRT) for prostate cancer...
  89. ncbi Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
    ..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
  90. ncbi Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation
    Charles J Rosser
    Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Gene Ther 11:273-9. 2004
    ..These findings suggest that overexpression of Bcl-2 result in radioresistance and inability of radiation to cause its typical G2M cell-cycle arrest...